Acute AKT signaling increases glucose phosphorylation and contribution to glycogen in hepatocytes
Insulin's regulation of hepatic glucose production and glycogen is critical for postprandial glucose disposal. AKT, a serine-threonine kinase and insulin signaling intermediate, regulates liver glucose metabolism through transcriptional and posttranslational mechanisms. However, current knowledge largely stems from genetic loss-of-function models, precluding observation of AKT's non-transcriptional effects. To measure rapid changes to glucose and glycogen metabolism, isotope tracing using [U- 13 C]-glucose and [U- 14 C]-glucose was coupled with the AKT inhibitor MK-2206 in primary rat hepatocytes. MK-2206 treatment decreased AKT phosphorylation and glucose contribution to glucose 6-phosphate and uridine diphosphate glucose within minutes without affecting metabolite pool sizes or protein levels of glucokinase, glucose 6-phosphatase, or phosphoenolpyruvate carboxykinase. MK-2206 also decreased glucose contribution to glycogen, independent of glycogen breakdown or glycogen synthase phosphorylation. These results demonstrate that AKT acutely regulates glucose contribution to glycogen and upstream precursors, suggesting a transcription-independent mechanism that is proximal to glucose 6-phosphate generation for glycogen synthesis.
Authors
- Joseph A. Baur (ORCID: https://orcid.org/0000-0001-8262-6549)
- Paul M. Titchenell (ORCID: https://orcid.org/0000-0002-9941-5649)
- Joshua D. Rabinowitz (ORCID: https://orcid.org/0000-0002-1247-4727)
- Megan Stefkovich (ORCID: https://orcid.org/0000-0002-8983-5551)
- Talia Coopersmith
- Won Dong Lee
Institutions
- Yonsei University (KR)
- Princeton University (US)
- University of the Arts (US)
- Penn Center for AIDS Research (US)
- Ludwig Cancer Research (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- iScience
- Published
- 2026-07-30
- DOI
- https://doi.org/10.1016/j.isci.2026.116956
- Primary Topic
- PI3K/AKT/mTOR signaling in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute of Diabetes and Digestive and Kidney Diseases